LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | CGP60474 | 10 | uM | LJP6 | 2 | G01 | 72 | hr | 868 | 456 | 3652 | 0.1249 | -0.2670 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP6 | 3 | G01 | 72 | hr | 868 | 585 | 3587 | 0.1631 | -0.1754 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP5 | 1 | F01 | 72 | hr | 868 | 566 | 3286 | 0.1722 | -0.1997 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP5 | 2 | F01 | 72 | hr | 868 | 593 | 3505 | 0.1692 | -0.1724 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP5 | 3 | F01 | 72 | hr | 868 | 601 | 3440 | 0.1747 | -0.1690 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 1 | I12 | 72 | hr | 868 | 3982 | 3429 | 1.1610 | 1.1564 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 2 | I12 | 72 | hr | 868 | 4166 | 3652 | 1.1407 | 1.1312 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 3 | I12 | 72 | hr | 868 | 4106 | 3587 | 1.1446 | 1.1364 |
MDA-MB-231 | PD173074 | 0.12 | uM | LJP6 | 1 | I11 | 72 | hr | 868 | 3890 | 3429 | 1.1342 | 1.1312 |
MDA-MB-231 | PD173074 | 0.12 | uM | LJP6 | 2 | I11 | 72 | hr | 868 | 3858 | 3652 | 1.0564 | 1.0537 |
MDA-MB-231 | PD173074 | 0.12 | uM | LJP6 | 3 | I11 | 72 | hr | 868 | 4009 | 3587 | 1.1176 | 1.1116 |
MDA-MB-231 | PD173074 | 0.37 | uM | LJP6 | 1 | I10 | 72 | hr | 868 | 3614 | 3429 | 1.0537 | 1.0535 |
MDA-MB-231 | PD173074 | 0.37 | uM | LJP6 | 2 | I10 | 72 | hr | 868 | 3547 | 3652 | 0.9713 | 0.9721 |
MDA-MB-231 | PD173074 | 0.37 | uM | LJP6 | 3 | I10 | 72 | hr | 868 | 3618 | 3587 | 1.0086 | 1.0083 |
MDA-MB-231 | PD173074 | 1.11 | uM | LJP6 | 1 | I09 | 72 | hr | 868 | 3201 | 3429 | 0.9333 | 0.9315 |
MDA-MB-231 | PD173074 | 1.11 | uM | LJP6 | 2 | I09 | 72 | hr | 868 | 3952 | 3652 | 1.0821 | 1.0776 |
MDA-MB-231 | PD173074 | 1.11 | uM | LJP6 | 3 | I09 | 72 | hr | 868 | 3782 | 3587 | 1.0543 | 1.0523 |
MDA-MB-231 | PD173074 | 3.33 | uM | LJP6 | 1 | I08 | 72 | hr | 868 | 3544 | 3429 | 1.0333 | 1.0333 |
MDA-MB-231 | PD173074 | 3.33 | uM | LJP6 | 2 | I08 | 72 | hr | 868 | 3642 | 3652 | 0.9973 | 0.9974 |
MDA-MB-231 | PD173074 | 3.33 | uM | LJP6 | 3 | I08 | 72 | hr | 868 | 3770 | 3587 | 1.0509 | 1.0491 |
MDA-MB-231 | PD173074 | 10 | uM | LJP6 | 1 | I07 | 72 | hr | 868 | 1188 | 3429 | 0.3464 | 0.1715 |
MDA-MB-231 | PD173074 | 10 | uM | LJP6 | 2 | I07 | 72 | hr | 868 | 1347 | 3652 | 0.3688 | 0.2361 |
MDA-MB-231 | PD173074 | 10 | uM | LJP6 | 3 | I07 | 72 | hr | 868 | 1285 | 3587 | 0.3582 | 0.2112 |
MDA-MB-231 | Crizotinib | 0.04 | uM | LJP5 | 1 | A24 | 72 | hr | 868 | 2398 | 3286 | 0.7297 | 0.6973 |
MDA-MB-231 | Crizotinib | 0.04 | uM | LJP5 | 2 | A24 | 72 | hr | 868 | 2728 | 3505 | 0.7782 | 0.7658 |